Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with high-risk prostate cancer confirmed by a tissue sample (biopsy), meeting at least one of the following: an aggressive cancer grade (Gleason score of 8 or higher); cancer that has spread to the seminal vesicles or nearby structures; a PSA level above 20 (or above 10 if you take finasteride); or cancer that has spread to nearby lymph nodes in the pelvic or lower abdominal area
- You are generally able to carry out daily activities, even if you have some symptoms (confirm with trial site what level of daily function is required)
- You have had a full blood count test done within the last 90 days before joining the study
- Your white blood cell count (infection-fighting cells) is at a healthy enough level (confirm specific number with trial site)
- Your platelet count (cells that help blood clot) is at a healthy enough level (confirm specific number with trial site)
- Your red blood cell level (hemoglobin) meets the minimum required — blood transfusions to reach this level are allowed
- You are able to read and sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have cancer that has spread to your bones, as shown by a bone scan or other imaging
- You have cancer that has spread to distant lymph nodes (outside the local area), as shown by a CT or MRI scan
- You have previously had surgery to remove your prostate (prostatectomy) or had cryotherapy (freezing treatment) for prostate cancer
- You have previously had radiation therapy or internal radiation (brachytherapy) to the same area being treated in this trial, in a way that would overlap with new radiation treatment
- You have certain serious or uncontrolled health conditions, including but not limited to: inflammatory bowel disease, HIV infection, an active or ongoing infection, severe heart failure, unstable chest pain, irregular heart rhythm, or mental health or personal circumstances that would make it difficult to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pretesh R Patel, Emory University Hospital/Winship Cancer Institute
Phone: 404-778-3473
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute grade 2+ gastrointestinal (GI) toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.